Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Solid Tumor Cancer × Cisplatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Squamous Cell Carcinoma of Head and Neck 9 Nasopharyngeal Carcinoma 9 Uterine Cervical Neoplasms 7 Small Cell Lung Carcinoma 6 Biliary Tract Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Thymoma 2 Recurrence 2 Ovarian Neoplasms 2 Nasopharyngeal Neoplasms 2 Lung Neoplasms 2 Klatskin Tumor 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Squamous Cell Cancer of Head and Neck (SCCHN) 1 Solid Tumor Cancer 1 Sarcoma, Ewing 1 Rare Tumour 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Immunotherapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡